secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001213900-25-039783
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences replaces auditor Marcum with CBIZ CPAs after acquisition of attest business
--------------------------------------------------------------------------------

- Marcum resigned as independent auditor on May 2, 2025, due to CBIZ CPAs acquiring its attest business.
- Audit Committee approved engagement of CBIZ CPAs as new independent registered public accounting firm same day.
- Marcum's FY2024 audit report contained a going concern emphasis, but no adverse opinion or disclaimer.
- No disagreements or reportable events occurred with Marcum during FY2024 or through resignation date.
- Emmaus provided Marcum with a copy of this 8-K; Marcum's response letter (Exhibit 16.1) filed with SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390025039783/0001213900-25-039783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390025039783/ea0240955-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-039783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer